These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 35358643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q, Yip L, Chow MYT, Chow SF, Chan HK, Kwok PCL, Lam JKW.
    Int J Pharm; 2019 Apr 05; 560():144-154. PubMed ID: 30731259
    [Abstract] [Full Text] [Related]

  • 4. Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system.
    Yu YS, Xu H, AboulFotouh K, Williams G, Suman J, Sahakijpijarn S, Cano C, Warnken ZN, Wu KC, Williams RO, Cui Z.
    Int J Pharm; 2024 Mar 25; 653():123892. PubMed ID: 38350499
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.
    Longest PW, Golshahi L, Behara SR, Tian G, Farkas DR, Hindle M.
    J Aerosol Med Pulm Drug Deliv; 2015 Jun 25; 28(3):189-201. PubMed ID: 25192072
    [Abstract] [Full Text] [Related]

  • 7. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
    Liao Q, Lam ICH, Lin HHS, Wan LTL, Lo JCK, Tai W, Kwok PCL, Lam JKW.
    Int J Pharm; 2020 Jun 30; 584():119444. PubMed ID: 32445908
    [Abstract] [Full Text] [Related]

  • 8. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M, Alany RG, Calabrese G, Kaialy W, ElShaer A.
    Int J Pharm; 2022 Apr 05; 617():121601. PubMed ID: 35181460
    [Abstract] [Full Text] [Related]

  • 9. Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections.
    Saha T, Lyons N, Yue Yung DB, Quiñones-Mateu ME, Pletzer D, Das SC.
    Eur J Pharm Biopharm; 2024 Feb 05; 195():114170. PubMed ID: 38128743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA, Anderson KW, Zach Hilt J, McGarry RC, Mansour HM.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):699-711. PubMed ID: 23707466
    [Abstract] [Full Text] [Related]

  • 12. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr 16; 27(2):81-93. PubMed ID: 24502451
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.
    Farkas D, Hindle M, Bonasera S, Bass K, Longest W.
    J Aerosol Med Pulm Drug Deliv; 2020 Apr 16; 33(2):83-98. PubMed ID: 31464559
    [Abstract] [Full Text] [Related]

  • 15. Powder aerosol delivery through nasal high-flow system: In vitro feasibility and influence of process conditions.
    Okuda T, Tang P, Yu J, Finlay WH, Chan HK.
    Int J Pharm; 2017 Nov 25; 533(1):187-197. PubMed ID: 28830783
    [Abstract] [Full Text] [Related]

  • 16. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM, Baldassi D, Chan K, Adams NBP, Neumann A, Porras-Gonzalez DL, Wei X, Kneidinger N, Stoleriu MG, Burgstaller G, Witzigmann D, Luciani P, Merkel OM.
    J Control Release; 2022 Nov 25; 351():137-150. PubMed ID: 36126785
    [Abstract] [Full Text] [Related]

  • 17. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
    Saboti D, Maver U, Chan HK, Planinšek O.
    J Pharm Sci; 2017 Jul 25; 106(7):1881-1888. PubMed ID: 28285981
    [Abstract] [Full Text] [Related]

  • 18. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
    Wang J, Kutter JP, Mu H, Moodley A, Yang M.
    Int J Pharm; 2020 Nov 30; 590():119877. PubMed ID: 32927003
    [Abstract] [Full Text] [Related]

  • 19. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
    Hassan A, Farkas D, Longest W, Hindle M.
    Int J Pharm; 2020 Dec 15; 591():120027. PubMed ID: 33130220
    [Abstract] [Full Text] [Related]

  • 20. Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation.
    Pozzoli M, Rogueda P, Zhu B, Smith T, Young PM, Traini D, Sonvico F.
    Drug Dev Ind Pharm; 2016 Oct 15; 42(10):1660-8. PubMed ID: 26953090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.